LSD1-IN-33 (7d) is an orally effective inhibitor of LSD1, exhibiting an IC50 of 4.51 nM. It alleviates the activation of NRCFs induced by Ang II and reduces pathological cardiac hypertrophy and heart failure due to TAC-induced cardiac remodeling.
Target-Kategorie:
Histone Demethylase
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
